1-18 of 18
Natasha Galasso
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Peri-Transplant Radiation on Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant

Kelsey Baron, Esther Drill, Nivetha Ganesan, Reid W. Merryman, Matthew G. Mei, Robert Stuver, Sanjal H. Desai, Ayo S Falade, Siddharth Iyengar, Ivana Micallef, Lay She Ng, Ellie Casper, Natasha Galasso, Randa Tao, Savita Dandapani, Andrea Ng, Joachim Yahalom, Alex F. Herrera, Alison Moskowitz, Harsh Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4436.
https://doi.org/10.1182/blood-2023-173470
Published: 2023
Journal Articles

Reduced Dose Brentuximab Vedotin for Mycosis Fungoides Appears to Prolong Response Duration By Balancing Efficacy and Tolerability

Brittney Munayirji, Niloufer Khan, Patricia Myskowski, Shamir Geller, Sarah Noor, Meenal Kapoor Kheterpal, Theresa Davey, Helen Hancock, Leslie Perez, Tayler Miller, Jamila Brutus, Nivetha Ganesan, Tiffany Chang, Gianna Mangiaracina, Richa Patel, Natasha Galasso, Ellie Casper, Paola Ghione, Robert Stuver, Zachary D. Epstein-Peterson, Melissa Pulitzer, Michael S. Khodadoust, Youn H. Kim, Steven M. Horwitz, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1702.
https://doi.org/10.1182/blood-2023-184898
Published: 2023
Journal Articles

Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies

Robert Stuver, Esther Drill, Nivetha Ganesan, Kelsey Baron, Ellie Casper, Tiffany Chang, Sanjal H. Desai, Ayo S Falade, Natasha Galasso, Alex F. Herrera, Matthew G. Mei, Reid W. Merryman, Ivana Micallef, Harsh Shah, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3069.
https://doi.org/10.1182/blood-2023-182143
Published: 2023
Journal Articles

Distinct Patterns of CD4+ and CD8+ T-Cell Clonal Expansion Enable Broad Clinical Responses to Pembrolizumab + GVD in Patients with Relapsed Hodgkin Lymphoma

Beatriz Wills, Jahan Rahman, Nivetha Ganesan, Gunjan L. Shah, Ariela Noy, Heiko Schoder, Joachim Yahalom, Anita Kumar, Lorenzo Falchi, Paul A. Hamlin, Maria Lia Palomba, William Johnson, Andrew M. Intlekofer, Philip Caron, Theresa Davey, Helen Hancock, Natasha Galasso, Brittney Munayirji, Ya Hui Lin, Alayna Santarosa, Ellie Casper, Georgio Pongas, Andrew D. Zelenetz, Craig H. Moskowitz, Gilles Salles, Santosha A Vardhana, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1623.
https://doi.org/10.1182/blood-2023-185083
Published: 2023
Journal Articles

Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Beatriz Wills, Nivetha Ganesan, Gunjan L. Shah, Phillip Wong, Kimon V. Argyropoulos, Filiz Sen, Ahmet Dogan, David J. Straus, Ariela Noy, Anita Kumar, Heiko Schoder, Laure Michaud, Maria Lia Palomba, Lorenzo Falchi, Oscar B Lahoud, Paul A. Hamlin, Joachim Yahalom, William T. Johnson, Andrew D. Zelenetz, Andrew M. Intlekofer, Colette Owens, Connie Lee Batlevi, Audrey Hamilton, Philip C Caron, Steven M. Horwitz, Natasha Galasso, Helen Hancock, Theresa Davey, Alayna Santarosa, Leslie Perez, Charisse Capadona, Brittney Munayirji, Matthew J. Matasar, Georgios Pongas, Ellie Casper, Gilles Salles, Craig H. Moskowitz, Santosha Vardhana, Alison J. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 9286–9288.
https://doi.org/10.1182/blood-2022-160206
Published: 2022
Journal Articles

Emapalumab for Malignancy-Associated Hemophagocytic Lymphohistiocytosis: The Memorial Sloan Kettering Cancer Center Experience

William T. Johnson, Zachary D. Epstein-Peterson, Nivetha Ganesan, Tiffany Chang, Natasha Galasso, Robert Stuver, Niloufer Khan, Gilles Salles, Alison J. Moskowitz, Santosha Vardhana, Steven M. Horwitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 3704–3706.
https://doi.org/10.1182/blood-2022-168063
Published: 2022
Journal Articles

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Clinical Trials & Observations
Alison J. Moskowitz, Paola Ghione, Eric Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor, Patricia Myskowski, Santosha Vardhana, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Alayna Santarosa, Jack Dowd, Obadi Obadi, Lauren Pomerantz, Nancy Yi, Samia Sohail, Natasha Galasso, Rachel Neuman, Brielle Liotta, William Blouin, Jeeyeon Baik, Mark B. Geyer, Ariela Noy, David Straus, Priyadarshini Kumar, Ahmet Dogan, Travis Hollmann, Esther Drill, Jurgen Rademaker, Heiko Schoder, Giorgio Inghirami, David M. Weinstock, Steven M. Horwitz
Journal: Blood
Blood (2021) 138 (26): 2828–2837.
https://doi.org/10.1182/blood.2021013379
Published: 2021
Includes: Supplemental data
Journal Articles

TP53 Mutations Identify High-Risk Peripheral T-Cell Lymphoma Patients Treated with CHOP-Based Chemotherapy

William T. Johnson, Nivetha Ganesan, Zachary D. Epstein-Peterson, Catherine Maccaro, Natasha Galasso, Craig S. Sauter, Rachel Neuman, Niloufer Khan, Alison J. Moskowitz, Ahmet Dogan, Steven M. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1367.
https://doi.org/10.1182/blood-2021-151779
Published: 2021
Journal Articles

Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, MD, Gunjan Shah, MD, Heiko Schöder, MD, Nivetha Ganesan, MPH, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Samia Sohail, BA, Alayna Santarosa, Lauren Pomerantz, BS, Christine Jarjies, MS, Natasha Galasso, BA, Rachel Neuman, Anita Kumar, MD, Oscar B Lahoud, MD, Connie Lee Batlevi, MDPhD, Paul A. Hamlin, MD, David J. Straus, MD, Ildefonso Rodriguez-Rivera, MD, Colette Owens, MD, Philip Caron, MD PhD, Andrew M. Intlekofer, MD PhD, Audrey Hamilton, MD, Steven M. Horwitz, MD, Lorenzo Falchi, MD, Erel Joffe, MD MSc, Maria Lia Palomba, Ariela Noy, MD, Matthew J Matasar, MD, Georgios Pongas, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Joachim Yahalom, MD, Andrew D Zelenetz, MD PhD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-138434
Published: 2020
Journal Articles

Clinical Characteristics and Follow-up Post-Surgery of Women with Bia-ALCL Operated at a Single Institution

Paola Ghione, MD, Joshua Vorstenbosch, MD PhD FRCSC, Peter G. Cordeiro, MD, Maria E. Arcila, MD, Alison J. Moskowitz, MD, Colette Owens, MD, Natasha Galasso, BA, Jonas A. Nelson, MD, Ahmet Dogan, MD PhD, Colleen M. McCarthy, MD FRCSC, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134393
Published: 2020
Journal Articles

Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term

Paola Ghione, MD, Peter Cordeiro, MD, Venkatraman Seshan, PhD, Natasha Galasso, Nivetha Ganesan, MPH, Qunying Hu, Ahmet Dogan, MD PhD, Steven M. Horwitz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2842.
https://doi.org/10.1182/blood-2019-122572
Published: 2019
Journal Articles

Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma

Alison J. Moskowitz, MD, Paola Ghione, MD, Eric D Jacobsen, MD, Jia Ruan, MD PhD, Jonathan H. Schatz, MD, Sarah Noor, MD, Patricia Myskowski, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Obadi Obadi, Carlissa Onwasigwe, MPH, Nivetha Ganesan, MPH, Lauren Pomerantz, BS, Christine Jarjies, MS, Priyadarshini Kumar, Allison Sigler, Mark B. Geyer, MD, Ariela Noy, MD, David J. Straus, MD, Travis Hollmann, MD, Ahmet Dogan, MD PhD, Natasha Galasso, Giorgio Inghirami, MD, David M. Weinstock, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4019.
https://doi.org/10.1182/blood-2019-125017
Published: 2019
Journal Articles

The Combination of Duvelisib, a PI3K-δ,γ Inhibitor, and Romidepsin Is Highly Active in Relapsed/Refractory Peripheral T-Cell Lymphoma with Low Rates of Transaminitis: Results of Parallel Multicenter, Phase 1 Combination Studies with Expansion Cohorts

Steven M. Horwitz, MD, Alison J. Moskowitz, MD, Eric D Jacobsen, MD, Neha Mehta-Shah, MD, Michael S Khodadoust, MDPhD, David C. Fisher, MD PhD, Patricia Myskowski, MD, Erica B.K. Wang, MD, Marianne Tawa, RN, MSN, ANP, Theresa Davey, MMSc, PA-C, William Blouin, MBA, Helen Hancock, NP, Nivetha Ganesan, MPH, Natasha Galasso, BA, Evan Marzouk, BA, Alexandra Bahgat, BS, Hallie Jester, BA, Sophia Fong, BS, Abeer Butt, BS, Ahmet Dogan, MD PhD, Youn H. Kim, MD, David M Weinstock, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 683.
https://doi.org/10.1182/blood-2018-99-115241
Published: 2018
Journal Articles

Durable Responses Observed with JAK Inhibition in T-Cell Lymphomas

Alison J. Moskowitz, MD, Eric Jacobsen, MD, Jia Ruan, MD PhD, Jonathan H. Schatz, MD, Obadi Obadi, Kristin Motylinski, Christine Jarjies, MS, Natasha Galasso, Helen Hancock, NP, Theresa Davey, MPAS, Patricia Myskowski, MD, Ahmet Dogan, MD PhD, Giorgio Inghirami, MD, David M Weinstock, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2922.
https://doi.org/10.1182/blood-2018-99-112123
Published: 2018
Journal Articles

In Vitro , In Vivo , and Parallel Phase I Evidence Support the Safety and Activity of Duvelisib, a PI3K-δ,γ Inhibitor, in Combination with Romidepsin or Bortezomib in Relapsed/Refractory T-Cell Lymphoma

Alison J. Moskowitz, MD, Raphael Koch, MD, Neha Mehta-Shah, MD, Patricia Myskowski, MD, Meenal Kheterpal, MD, Ahmet Dogan, MD PhD, Theresa Davey, MPAS, Natasha Galasso, BA, Marzouk Evan, BA, Monica Shah, BA, Nivetha Ganesan, BS, Lakeisha Lubin, BS, Youn H. Kim, MD, Michael Khodadoust, MD PhD, Timothy Almazan, MD, Julia Dai, MD, Eric D. Jacobsen, MD, David M. Weinstock, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 819.
https://doi.org/10.1182/blood.V130.Suppl_1.819.819
Published: 2017
Journal Articles

A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory B- and T-Cell Lymphomas

Neha Mehta-Shah, MD, Alison J. Moskowitz, MD, Matthew A. Lunning, DO, Peggy Lynch, Mark Scheuerman, Veenna Minnal, Natasha Galasso, BA, Anita Kumar, MD, John Gerecitano, MD PhD, Andrew D. Zelenetz, MD PhD, Paul A. Hamlin, MD, Ariela Noy, MD, Matthew J. Matasar, MD, Maria Lia Palomba, MD, Anas Younes, MD, Wendy Schaffer, MD, Ravinder Grewal, MD, Jurgen Rademaker, MD, Craig S. Sauter, MD, Parastoo B. Dahi, MD, Patricia Myskowski, MD, Meenal Kheterpal, MD, Ahmet Dogan, MD PhD, Melissa Pulitzer, MD, Lakeisha Lubin, BS, Laura Tang, Pharm. D, Nivetha Ganesan, BS, Ai Ni, PhD, Steven M. Horwitz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 821.
https://doi.org/10.1182/blood.V130.Suppl_1.821.821
Published: 2017
Journal Articles

High-Depth, Targeted, Next Generation Sequencing Identifies Novel Genetic Alterations in Cutaneous T-Cell Lymphoma

Kimon V. Argyropoulos, MD, Steven M Horwitz, MD, Franck Rapaport, PhD, Enrico Velardi, PhD, Patricia Myskowski, MD, Christiane Querfeld, Melissa Pulitzer, MD, Ahmet Dogan, MD PhD, Meighan Gallagher, MA, Nicholas D. Socci, PhD, Ross L. Levine, MD, Minal Patel, BA, Natasha Galasso, Marcel van den Brink, MD PhD, Lia Palomba, MD
Journal: Blood
Blood (2015) 126 (23): 1485.
https://doi.org/10.1182/blood.V126.23.1485.1485
Published: 2015
Journal Articles

Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Salvage Chemotherapy and Intention to Transplant in the Rituximab Era

Santosha A. Vardhana, MD PhD, Craig H. Moskowitz, MD, Craig S. Sauter, MD, Matthew J Matasar, MD MS, Natasha Galasso, Kaitlin M Woo, MS, Zhigang Zhang, PhD
Journal: Blood
Blood (2015) 126 (23): 1986.
https://doi.org/10.1182/blood.V126.23.1986.1986
Published: 2015